Epic Sciences Partners with Penn’s Abramson Cancer Center on Therapy Discoveries through Liquid Biopsy
The collaboration will explore biomarkers, identified by analysis of circulating tumor cells at a single-cell resolution, that are predictive of response to personalized cancer therapeutics.
Read More